TY - GEN
T1 - Achieving minimal residual disease (MRD) negativity in CLL is independently associated with improved progression-free and overall survival and is an appropriate end-point of therapy
AU - Kwok, Marwan Cheng Kuang
AU - Rawstron, Andy C
AU - Varghese, Abraham
AU - Hillmen, Peter
PY - 2010
Y1 - 2010
N2 - Eradication of detectable minimal residual disease (MRD) in CLL is associated with improved progression-free and overall survival. Herewe present the first multivariate analysis from 137 responding CLLpatients treated between 1996 and 2007 with bone marrow MRD assessment by multicolour flow cytometry (sensitivity: 1 CLL cell in10,000 leukocytes [HMDS]).
AB - Eradication of detectable minimal residual disease (MRD) in CLL is associated with improved progression-free and overall survival. Herewe present the first multivariate analysis from 137 responding CLLpatients treated between 1996 and 2007 with bone marrow MRD assessment by multicolour flow cytometry (sensitivity: 1 CLL cell in10,000 leukocytes [HMDS]).
UR - https://www.researchgate.net/publication/295131459_Achieving_minimal_residual_disease_MRD_negativity_in_CLL_is_independently_associated_with_improved_progression-free_and_overall_survival_and_is_an_appropriate_end-point_of_therapy
M3 - Conference contribution
VL - 149
T3 - British Journal of Haematology
SP - 20
BT - British Journal of Haematology
ER -